c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Kura outlines up to $300M Oberland funding and plans ~40-patient darlifarnib registrational study in 1H 2027
Seeking Alpha | Nov 11, 2026 12:12 AM EST
Read original article